MX9705572A - Complejos estables para el suministro de farmacos que contienen lipidos y metodos para su produccion. - Google Patents
Complejos estables para el suministro de farmacos que contienen lipidos y metodos para su produccion.Info
- Publication number
- MX9705572A MX9705572A MX9705572A MX9705572A MX9705572A MX 9705572 A MX9705572 A MX 9705572A MX 9705572 A MX9705572 A MX 9705572A MX 9705572 A MX9705572 A MX 9705572A MX 9705572 A MX9705572 A MX 9705572A
- Authority
- MX
- Mexico
- Prior art keywords
- drug delivery
- production
- complexes
- methods
- lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Abstract
Se describen novedosos complejos estables para la entrega de drogas, concentrados, biologicamente activos, listos para ser utilizados y que contienen lípidos, métodos para su utilizacion. La actividad biologica de los complejos producidos, es comparable a la de las formulaciones preparadas de acuerdo con el método del arte anterior basado en el mezclado conjunto; y, al ser purificados, los complejos producidos mediante el método de la presente invencion, tienen una concentracion de 50 a 500 veces la de los componentes de los complejos formados mediante el mezclado conjunto. El método descrito en la presente, permite la produccion en gran escala de sistemas entregadores de drogas y que contienen lípidos, utiles para la terapia basada en los genes, y para otras aplicaciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08376701 | 1995-01-23 | ||
US08/376,701 US5795587A (en) | 1995-01-23 | 1995-01-23 | Stable lipid-comprising drug delivery complexes and methods for their production |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9705572A true MX9705572A (es) | 1998-06-28 |
MXPA97005572A MXPA97005572A (es) | 1998-10-30 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
AU4703796A (en) | 1996-08-14 |
DK0814777T3 (da) | 2003-03-03 |
DE69624801D1 (de) | 2002-12-19 |
US20100184953A1 (en) | 2010-07-22 |
IL116856A0 (en) | 1996-07-23 |
AU709773B2 (en) | 1999-09-09 |
ATE227563T1 (de) | 2002-11-15 |
ZA96503B (en) | 1996-08-07 |
PT814777E (pt) | 2003-03-31 |
JP4074338B2 (ja) | 2008-04-09 |
CA2211118A1 (en) | 1996-08-01 |
US20130281382A1 (en) | 2013-10-24 |
US8771728B2 (en) | 2014-07-08 |
US20080153166A1 (en) | 2008-06-26 |
WO1996022765A1 (en) | 1996-08-01 |
EP0814777B1 (en) | 2002-11-13 |
CA2211118C (en) | 2009-06-30 |
US20120178702A1 (en) | 2012-07-12 |
DE69624801T2 (de) | 2003-04-10 |
US5795587A (en) | 1998-08-18 |
EP0814777A1 (en) | 1998-01-07 |
US7655468B2 (en) | 2010-02-02 |
ES2186769T3 (es) | 2003-05-16 |
JPH10512882A (ja) | 1998-12-08 |
US7993672B2 (en) | 2011-08-09 |
CN1177291A (zh) | 1998-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL116856A0 (en) | Stable-lipid- comprising drug delivery complexes and methods for their production | |
HU9200823D0 (en) | Process for the production of cyclical carbamide derivatives and medical preparations containing them as active agents | |
AU7576896A (en) | Lipopolyamines as transfection agents and their pharmaceutical applications | |
ES2058411T3 (es) | Sustancia fr 901228 y su preparacion. | |
AU6701890A (en) | Process for the production of biologically active protein | |
UA43348C2 (uk) | Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад | |
HUT76511A (en) | Benzoyl derivatives, preparation and use thereot | |
TW225532B (es) | ||
EG18334A (en) | Pyrozoline compounds and their use as pesticides | |
EP0657534A4 (en) | ANTIALLERGIC AGENT. | |
MY102918A (en) | Purified antineoplaston fractions and methods of treating neoplastic disease. | |
MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
ES2002053A6 (es) | Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi. | |
ES8403157A1 (es) | Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral. | |
DK0952853T3 (da) | Konjugat omfattende et aktivt middel, et polypeptid og en polyether | |
AR002272A1 (es) | Uso de amidas de fenilciclohexilcarboxilicos | |
DK347788A (da) | Teicoplaninlignende forbindelser, fremgangsmaade og mikroorganisme til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser | |
ATE25708T1 (de) | Biologisch aktive konjugate, ihre herstellung und ihre anwendung. | |
CA2072797A1 (en) | Use of tri (n-butyl) phosphate at low ph in solutions of biologically active proteins for enhanced virucidal activity | |
IL125474A0 (en) | Solid instant-release forms of administration and process for producing the same | |
MD970230A (en) | Diamine ether diclavulanate and process for preparation thereof | |
AU625831B2 (en) | Solubilization of t-pa | |
AU578125B2 (en) | Pyrazine diazohydroxide compounds | |
EP0332999A3 (en) | Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them | |
UA5743C2 (uk) | Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання |